Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Centogene B V

Current price
0.39 USD -0.0002 USD (-0.05%)
Last closed 0.37 USD
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 10 846 038 USD
Yield for 12 month -51.94 %
21.11.2021 - 28.11.2021

Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA sequencing, biochemical testing, and RNA sequencing; CentoCloud, a cloud-based Software as a Service platform, which enables laboratories to analyze, interpret, and report genomic variants for rare disease diagnostics; FilterTool, a web-based application for genetic data interpretation; and NEW CentoGenome, a Next Generation Sequencing (NGS)-based assay that provides diagnostic information to accelerate access to potential treatment options. The company also offers target and drug screening, clinical development, and market access and expansion, as well as CENTOGENE Biodatabank licenses and insight reports. In addition, it provides early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services, such as whole exome sequencing, whole genome sequencing, and multiomic testing solutions to physicians, laboratories, and hospitals directly or through distributors. The company was founded in 2006 and is headquartered in Rostock, Germany. Address: Am Strande 7, Rostock, Germany, 18055

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

1.51 USD

P/E ratio

Dividend Yield

Current Year

+51 707 325 USD

Last Year

+51 633 245 USD

Current Quarter

+13 390 949 USD

Last Quarter

+14 184 922 USD

Current Year

+12 627 470 USD

Last Year

+21 492 734 USD

Current Quarter

+4 837 796 USD

Last Quarter

+6 289 787 USD

Key Figures CNTG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -33 095 000 USD
Operating Margin TTM -86.31 %
PE Ratio
Return On Assets TTM -27.61 %
PEG Ratio
Return On Equity TTM -1375.33 %
Wall Street Target Price 1.51 USD
Revenue TTM 50 708 000 USD
Book Value -0.55 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 11.3 %
Dividend Yield
Gross Profit TTM 35 904 000 USD
Earnings per share -1.37 USD
Diluted Eps TTM -1.37 USD
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin -77.64 %

Dividend Analytics CNTG

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CNTG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CNTG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.2731
Price Sales TTM 0.3053
Enterprise Value EBITDA -2.314
Price Book MRQ 0.857

Financials CNTG

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CNTG

For 52 weeks

0.35 USD 1.98 USD
50 Day MA 0.53 USD
Shares Short Prior Month 40 118
200 Day MA 0.95 USD
Short Ratio 0.16
Shares Short 27 371
Short Percent 0.23 %

Dynamics of changes in the value of assets




430.16 USD Microsoft Corporation +3.16 (+0.74%)
Detailed analytics

ETF funds



14.70 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.1 (+0.64%)
Detailed analytics



2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics